Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase 1b study

Malaria:

(2012) Behzad Nadjm et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults

(2012) Pauline Byakika-Kibwika et al.   MALARIA JOURNAL

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

(2012) Annemarie R Kreeftmeijer-Vegter et al.   MALARIA JOURNAL

Intravenous Artesunate for the Treatment of Severe Malaria

(2010) Karl M Hess et al.   ANNALS OF PHARMACOTHERAPY

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

(2010) Arjen M Dondorp et al.   LANCET

Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins

(2010) Qigui Li et al.   TOXICOLOGY

Pharmacokinetic Profiles of Artesunate After Single Intravenous Doses at 0.5, 1, 2, 4, and 8 mg/kg in Healthy Volunteers: A Phase I Study

(2009) Qigui Li et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Artesunate for the Treatment of Severe Falciparum Malaria

(2008) Philip J. Rosenthal   NEW ENGLAND JOURNAL OF MEDICINE